Business · 06/01/2026Updated: 10/16/2026 · 1 min read
FDA Sets Regulatory Review Period for ZURZUVAE Patent Extension
Summary
The FDA has determined the regulatory review period for ZURZUVAE patent extension following USPTO submissions, as required by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →